Glucocorticoid receptor signaling in a bronchial epithelial cell line

Tricia D. LeVan, Fiona D. Behr, Karissa K. Adkins, Roger L. Miesfeld, John W. Bloom

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Glucocorticoids are an effective anti-inflammatory therapy for the treatment of asthma. The anti-inflammatory effects of glucocorticoids may be due to the inhibition of transcription factors that regulate cytokine synthesis. Because of the potential role of the bronchial epithelium in asthmatic inflammation and the possibility that this cell may be the main target of inhaled glucocorticoids, we have characterized glucocorticoid receptors (GR) and GR signaling in the human bronchial epithelial cell line BEAS-2B. Western blot analysis and radioligand binding studies demonstrated that BEAS-2B cells have functional GR that bind to dexamethasone (Dex) (dissociation constant = 5.6 nM and maximal density of binding sites = 228 ± 3.3 fmol/mg protein). GR were activated by Dex as assessed using a glucocorticoid-responsive reporter plasmid. Transfection of BEAS-2B cells with an activator protein-1 (AP-1) reporter construct followed by 12-O- tetradecanoylphorbol-13-acetate (TPA) treatment resulted in a fivefold induction of reporter gene activity. Transfection with a nuclear factor (NF)- κB reporter construct followed by tumor necrosis factor-α (TNF-α) treatment resulted in a 10-fold induction of reporter gene activity. Dex (10-7 M) markedly repressed both the induced AP-1 and NF-κB activity. The GR antagonist RU-486 inhibited the repressive effect of Dex on TNF-α- induced NF-κB activity by 81% but only counteracted the repressive effect of Dex on TPA-induced AP-1 activity by 43%. These studies demonstrate that cross-signaling between AP-1 and NF-κB with GR may explain the anti- inflammatory properties of glucocorticoids in airway epithelial cells.

Original languageEnglish (US)
Pages (from-to)L838-L843
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume272
Issue number5 16-5
StatePublished - May 1 1997

Fingerprint

Glucocorticoid Receptors
Dexamethasone
Glucocorticoids
Epithelial Cells
Transcription Factor AP-1
Cell Line
Anti-Inflammatory Agents
Tetradecanoylphorbol Acetate
Reporter Genes
Transfection
Tumor Necrosis Factor-alpha
Mifepristone
Plasmids
Transcription Factors
Asthma
Epithelium
Western Blotting
Binding Sites
Cytokines
Inflammation

Keywords

  • Activation
  • Activator protein-1
  • Nuclear factor- κB
  • Repression
  • Transcription factors

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Cite this

Glucocorticoid receptor signaling in a bronchial epithelial cell line. / LeVan, Tricia D.; Behr, Fiona D.; Adkins, Karissa K.; Miesfeld, Roger L.; Bloom, John W.

In: American Journal of Physiology - Lung Cellular and Molecular Physiology, Vol. 272, No. 5 16-5, 01.05.1997, p. L838-L843.

Research output: Contribution to journalArticle

LeVan, Tricia D. ; Behr, Fiona D. ; Adkins, Karissa K. ; Miesfeld, Roger L. ; Bloom, John W. / Glucocorticoid receptor signaling in a bronchial epithelial cell line. In: American Journal of Physiology - Lung Cellular and Molecular Physiology. 1997 ; Vol. 272, No. 5 16-5. pp. L838-L843.
@article{d1257421e0c948b6b1b05a8d6bb8d6b2,
title = "Glucocorticoid receptor signaling in a bronchial epithelial cell line",
abstract = "Glucocorticoids are an effective anti-inflammatory therapy for the treatment of asthma. The anti-inflammatory effects of glucocorticoids may be due to the inhibition of transcription factors that regulate cytokine synthesis. Because of the potential role of the bronchial epithelium in asthmatic inflammation and the possibility that this cell may be the main target of inhaled glucocorticoids, we have characterized glucocorticoid receptors (GR) and GR signaling in the human bronchial epithelial cell line BEAS-2B. Western blot analysis and radioligand binding studies demonstrated that BEAS-2B cells have functional GR that bind to dexamethasone (Dex) (dissociation constant = 5.6 nM and maximal density of binding sites = 228 ± 3.3 fmol/mg protein). GR were activated by Dex as assessed using a glucocorticoid-responsive reporter plasmid. Transfection of BEAS-2B cells with an activator protein-1 (AP-1) reporter construct followed by 12-O- tetradecanoylphorbol-13-acetate (TPA) treatment resulted in a fivefold induction of reporter gene activity. Transfection with a nuclear factor (NF)- κB reporter construct followed by tumor necrosis factor-α (TNF-α) treatment resulted in a 10-fold induction of reporter gene activity. Dex (10-7 M) markedly repressed both the induced AP-1 and NF-κB activity. The GR antagonist RU-486 inhibited the repressive effect of Dex on TNF-α- induced NF-κB activity by 81{\%} but only counteracted the repressive effect of Dex on TPA-induced AP-1 activity by 43{\%}. These studies demonstrate that cross-signaling between AP-1 and NF-κB with GR may explain the anti- inflammatory properties of glucocorticoids in airway epithelial cells.",
keywords = "Activation, Activator protein-1, Nuclear factor- κB, Repression, Transcription factors",
author = "LeVan, {Tricia D.} and Behr, {Fiona D.} and Adkins, {Karissa K.} and Miesfeld, {Roger L.} and Bloom, {John W.}",
year = "1997",
month = "5",
day = "1",
language = "English (US)",
volume = "272",
pages = "L838--L843",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "5 16-5",

}

TY - JOUR

T1 - Glucocorticoid receptor signaling in a bronchial epithelial cell line

AU - LeVan, Tricia D.

AU - Behr, Fiona D.

AU - Adkins, Karissa K.

AU - Miesfeld, Roger L.

AU - Bloom, John W.

PY - 1997/5/1

Y1 - 1997/5/1

N2 - Glucocorticoids are an effective anti-inflammatory therapy for the treatment of asthma. The anti-inflammatory effects of glucocorticoids may be due to the inhibition of transcription factors that regulate cytokine synthesis. Because of the potential role of the bronchial epithelium in asthmatic inflammation and the possibility that this cell may be the main target of inhaled glucocorticoids, we have characterized glucocorticoid receptors (GR) and GR signaling in the human bronchial epithelial cell line BEAS-2B. Western blot analysis and radioligand binding studies demonstrated that BEAS-2B cells have functional GR that bind to dexamethasone (Dex) (dissociation constant = 5.6 nM and maximal density of binding sites = 228 ± 3.3 fmol/mg protein). GR were activated by Dex as assessed using a glucocorticoid-responsive reporter plasmid. Transfection of BEAS-2B cells with an activator protein-1 (AP-1) reporter construct followed by 12-O- tetradecanoylphorbol-13-acetate (TPA) treatment resulted in a fivefold induction of reporter gene activity. Transfection with a nuclear factor (NF)- κB reporter construct followed by tumor necrosis factor-α (TNF-α) treatment resulted in a 10-fold induction of reporter gene activity. Dex (10-7 M) markedly repressed both the induced AP-1 and NF-κB activity. The GR antagonist RU-486 inhibited the repressive effect of Dex on TNF-α- induced NF-κB activity by 81% but only counteracted the repressive effect of Dex on TPA-induced AP-1 activity by 43%. These studies demonstrate that cross-signaling between AP-1 and NF-κB with GR may explain the anti- inflammatory properties of glucocorticoids in airway epithelial cells.

AB - Glucocorticoids are an effective anti-inflammatory therapy for the treatment of asthma. The anti-inflammatory effects of glucocorticoids may be due to the inhibition of transcription factors that regulate cytokine synthesis. Because of the potential role of the bronchial epithelium in asthmatic inflammation and the possibility that this cell may be the main target of inhaled glucocorticoids, we have characterized glucocorticoid receptors (GR) and GR signaling in the human bronchial epithelial cell line BEAS-2B. Western blot analysis and radioligand binding studies demonstrated that BEAS-2B cells have functional GR that bind to dexamethasone (Dex) (dissociation constant = 5.6 nM and maximal density of binding sites = 228 ± 3.3 fmol/mg protein). GR were activated by Dex as assessed using a glucocorticoid-responsive reporter plasmid. Transfection of BEAS-2B cells with an activator protein-1 (AP-1) reporter construct followed by 12-O- tetradecanoylphorbol-13-acetate (TPA) treatment resulted in a fivefold induction of reporter gene activity. Transfection with a nuclear factor (NF)- κB reporter construct followed by tumor necrosis factor-α (TNF-α) treatment resulted in a 10-fold induction of reporter gene activity. Dex (10-7 M) markedly repressed both the induced AP-1 and NF-κB activity. The GR antagonist RU-486 inhibited the repressive effect of Dex on TNF-α- induced NF-κB activity by 81% but only counteracted the repressive effect of Dex on TPA-induced AP-1 activity by 43%. These studies demonstrate that cross-signaling between AP-1 and NF-κB with GR may explain the anti- inflammatory properties of glucocorticoids in airway epithelial cells.

KW - Activation

KW - Activator protein-1

KW - Nuclear factor- κB

KW - Repression

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=0030965781&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030965781&partnerID=8YFLogxK

M3 - Article

C2 - 9176246

AN - SCOPUS:0030965781

VL - 272

SP - L838-L843

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 5 16-5

ER -